These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 760255

  • 1. Effect of tolbutamide on plasma catecholamine in insulin dependent diabetics.
    Sato T, Miura Y, Saito T, Ito M, Kokubun M, Sakuma H, Adachi M, Yoshinaga K.
    Tohoku J Exp Med; 1979 Jan; 127(1):97-8. PubMed ID: 760255
    [Abstract] [Full Text] [Related]

  • 2. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A, Matsuda K, Chiba M, Iimura Y, Yamagata S.
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [Abstract] [Full Text] [Related]

  • 3. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
    Mokuda O, Murakami I, Ikeda T, Tominaga M, Mashiba H.
    Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
    [Abstract] [Full Text] [Related]

  • 4. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A.
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug 20; 51(8):676-84. PubMed ID: 1237421
    [Abstract] [Full Text] [Related]

  • 5. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA, Morse EL, Amin PM.
    J Lab Clin Med; 1975 Sep 20; 86(3):395-409. PubMed ID: 168278
    [Abstract] [Full Text] [Related]

  • 6. [Autonomic nervous system and HCG secretion. I. Effects of catecholamines on the HCG secretion after intravenous loading with tolbutamide or insulin in normal subjects].
    Carducci Artenisio A, Allegra V, Albanese MC, Sprovieri M, Ragonese F, Alibrando S, Corsi V.
    Folia Endocrinol; 1973 Jun 20; 26(3):189-205. PubMed ID: 4740900
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH, Mahler RF, Hales CN.
    Lancet; 1976 Feb 28; 1(7957):444-7. PubMed ID: 55717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P, Ramahandridona G, Gerolami A.
    Diabetes; 1974 Nov 28; 23(11):896-901. PubMed ID: 4430416
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of a rapid intravenous injection of glucose or tolbutamide on plasma-insulin concentration in normal and diabetic subjects.
    Schreuder HB, Schopman W.
    Acta Physiol Pharmacol Neerl; 1967 Dec 28; 14(4):523. PubMed ID: 5582727
    [No Abstract] [Full Text] [Related]

  • 18. Plasma-insulin after tolbutamide in diabetics and non-diabetics.
    Deckert T, Mogensen P.
    Acta Med Scand; 1970 Apr 28; 187(4):309-12. PubMed ID: 5447096
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.